Find your path to Ugur
123 people in our graph share verified history with Ugur — schools, employers, funds. One of them is your warm intro.
Dan LynchunlockedUgur: together at Xilio Therapeutics (2020)
×4Ugur: together at Children's Research Institute at UT Southwestern
Ugur: together at Xilio Therapeutics
×6Ugur: together at Orta Doğu Teknik Üniversitesi / Middle East Technical University
About
Ugur Eskiocak is CEO and Co-Founder of Voro Therapeutics. He is a cancer biologist with experience in immuno-oncology, molecular biology, genome editing, and high throughput screening, with expertise spanning pre-clinical efficacy studies, drug development, IND-enabling studies, and Phase 1 clinical trials. He has led cross-functional research teams in both academic and industrial settings and holds project management certification.
Experience
- Voro TherapeuticsCEO & Co-Foundercurrent2023 — present
- Alloy Therapeutics, Inc.Entrepreneur In Residence2022 — 2024
- Janux TherapeuticsSenior Director, Translational Sciences2021 — 2022
- TakedaTranslational Strategy Lead, Immuno-Oncology2020 — 2021
- Xilio Therapeutics, Inc.Director of In Vivo Pharmacology2019 — 2020
- Compass Therapeutics LLCAssociate Director, In Vivo Immunopharmacology2018 — 2019
- Compass Therapeutics LLCSenior Scientist, Group Leader – In Vivo Immunopharmacology2017 — 2018Greater Boston
- Compass Therapeutics LLCScientist II2016 — 2017Greater Boston
- Children's Research Institute at UT SouthwesternPostdoctoral Scientist - Lab of Sean J Morrison2011 — 2016Dallas, TX
- Children's Research Institute at UT SouthwesternGraduate Research Student - Lab of Jerry W Shay & Woodring E Wright2007 — 2011Dallas, TX
- Middle East Technical UniversityMasters Research Student2006 — 2007Bursa, Türkiye
- OBITEKResearcher & Salesman2004 — 2007Bursa, Türkiye
Skills & more
Drug Discovery7High Throughput Screening7Assay Development5In Vivo3Animal Models3Cell Culture8Cell Biology14Metabolism2Cancer6Life Sciences1Biotechnology4Molecular Biology9
+10 more
Genetic EngineeringWestern BlottingFlow CytometryFACSImmunohistochemistryImmunocytochemistryConfocal MicroscopyPCRMolecular CloningSequencingLanguages English · Turkish
- MSc — Middle East Technical University
- PhD — UT Southwestern Careers
From Ugur's professional profile.
Colleagues at 82VS
Andrei Ramirez-Valdez
Venture Associate at 82VS
Andrew Peterson
Founder / EIR at 82VS
Arthur Suckow
Investor at 82VS
Caitlin Tolman
Chief Operating Officer at 82VS
Colby Jordan
Vice President, Capital Formation at 82VS
Dongxing Zha
Founder / EIR at 82VS
Errik Anderson
Board Director at Basecamp Fund
Hemanta Baruah
Founder / EIR at 82VS
Frequently asked questions
- Who is Ugur Eskiocak?
- Ugur Eskiocak is CEO and Co-Founder of Voro Therapeutics. He is a cancer biologist with experience in immuno-oncology, molecular biology, genome editing, and high throughput screening, with expertise spanning pre-clinical efficacy studies, drug development, IND-enabling studies, and Phase 1 clinical trials. He has led cross-functional research teams in both academic and industrial settings and holds project management certification.
- Where does Ugur Eskiocak work?
- Ugur Eskiocak is Founder / EIR at 82VS.
- Where did Ugur Eskiocak go to school?
- Ugur Eskiocak studied at UT Southwestern Medical Center (Doctor of Philosophy (Ph.D.), Cancer Biology); Orta Doğu Teknik Üniversitesi / Middle East Technical University (Master’s Degree, Biology); Orta Doğu Teknik Üniversitesi / Middle East Technical University (Bachelor’s Degree, Molecular Biology and Genetics).
Same school
Also attended UT Southwestern Medical Center18
Lauren TyraInvestor at Green Park & Golf VenturesHui TianPartner at The Column GroupDeng MaoInvestment Manager at Yonjin Venture LLCOscar MoralezFounder and Managing Partner at Boomerang VenturesJill MooneyAdvisor at Avalon BioVenturesAbby AlbrightCo-Founder and Investor at WXR Fund
+ 12 more
Also attended Orta Doğu Teknik Üniversitesi / Middle East Technical University63
Cem BaytokManaging Partner at IdacapitalGülce KoçInvestment Manager at IdacapitalMurat BicerGeneral Partner at CRV (Charles River Ventures)Umut EserVenture Partner at Magnetic VenturesAniqua BokhariLegal Counsel at Red Cell IncubationPiruze SabuncuPartner at Square Peg Capital
)
+ 57 more
Shared employers
Also worked at Voro Therapeutics3
Also worked at Alloy Therapeutics, Inc.21
Jesse RobbinsFounder and Investor in AI Developer ToolsUlrik B. NielsenGeneral Partner at Mission BiocapitalChaya PatelPrincipal at Mission BiocapitalErrik AndersonBoard Director at Basecamp FundAlasdair ThongFounding Partner at Selvedge VentureEsra BerkolChief of Staff at Selvedge Venture
+ 15 more
Also worked at Takeda52
Rebecca RedfieldSenior Associate at .406 VenturesAtsushi ShimadaSenior Principal at AN Venture PartnersDai HataAssociate at AN Venture PartnersJulie KimRepresentative Director – President and CEO at Takeda VenturesAkiko AmakawaCEO Chief of Staff at Takeda VenturesAsuka MiyabashiraPresident, Japan Pharma Business Unit at Takeda Ventures
+ 46 more
Also worked at Xilio Therapeutics, Inc.7
Dan LynchInvestor at GV (Google Ventures)Nessan BerminghamInvestor at Khosla VenturesAlex Badamchi-ZadehVice President at SV Health InvestorsKeno GutierrezGeneral Partner at BioGeneration VenturesPeter DudekPresident at MRL Ventures FundTim ClacksonFounder at IDRx
+ 1 more